PDL BioPharma, Inc. Total Liabilities
PDL BioPharma, Inc. had Total Liabilities of $100.66 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2021-03-29
- 2020-06-30: Liabilities $100.66M.
- 2020-03-31: Liabilities $106.69M.
- 2019-12-31: Liabilities $123.93M; Liabilities as first filed $122.84M.
- 2019-09-30: Liabilities $227.71M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2020-06-30 | $100.66M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $106.69M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $123.93M 10-K · filed 2021-03-29 | $122.84M 10-K · filed 2020-03-11 |
| 2019-09-30 | $227.71M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $225.04M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $229.75M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $235.73M 8-K · filed 2020-06-29 | $233.96M 10-K · filed 2019-03-15 |
| 2018-09-30 | $245.04M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $233.37M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $257.29M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $397.23M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $400.86M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $483.17M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $474.84M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $459.96M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $462.21M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $310.54M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $312.84M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $316.25M 10-K · filed 2017-03-01 | $320.23M 10-K · filed 2016-02-23 |
| 2015-09-30 | $424.64M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $468.33M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $662.19M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $501.91M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $577.86M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $619.74M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $650.37M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $430.47M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $376.79M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $402.69M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $406.48M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $348.09M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $365.38M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $420.94M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $478.74M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $473.74M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $513.76M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $577.77M 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $619.91M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $640.85M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $562.05M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $706.39M 10-Q · filed 2010-07-29 | |
| 2009-12-31 | $754.36M 10-K · filed 2011-03-01 |